Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space Expected milestones over the ...
Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the ...
Results were announced from a trial evaluating durvalumab with FLOT chemo as perioperative treatment for resectable early stage gastric/GEJ cancers.
The researchers called for further study to understand the mechanism of the relationship between obesity and ICI outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback